Journal of Biological Chemistry
Volume 289, Issue 47, 21 November 2014, Pages 32926-32936
Journal home page for Journal of Biological Chemistry

Signal Transduction
The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation*

https://doi.org/10.1074/jbc.M114.579961Get rights and content
Under a Creative Commons license
open access

Lysosome rupture triggers NLRP3 inflammasome activation in macrophages. However, the underlying mechanism is not fully understood. Here we showed that the TAK1-JNK pathway, a MAPK signaling pathway, is activated through lysosome rupture and that this activation is necessary for the complete activation of the NLRP3 inflammasome through the oligomerization of an adapter protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). We also revealed that the activation of the TAK1-JNK pathway is sustained through Ca2+ ions and that calcium/calmodulin-dependent protein kinase type II functions upstream of the TAK1-JNK pathway and specifically regulates lysosome rupture-induced NLRP3 inflammasome activation. These data suggest a novel role for the TAK1-JNK pathway as a critical regulator of NLRP3 inflammasome activation.

c-Jun N-terminal Kinase (JNK)
Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)
Inflammasome
Innate Immunity
Mitogen-activated Protein Kinase (MAPK)
Signal Transduction
NLRP3
TAK1
Lysosome Rupture
siRNA Screen

Cited by (0)

*

This work was supported by KAKENHI from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Global Center of Education and Research for Chemical Biology of the Diseases, by the Global Center of Excellence Program (GCOE) Program, by the “Understanding of Molecular and Environmental Bases for Brain Health” study conducted under the Strategic Research Program for Brain Sciences by MEXT, by the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation, by the Funding Program for Next Generation World-leading Researchers, by the Nagase Science and Technology Foundation, by the Astellas Foundation for Research on Metabolic Disorders, and by the Takeda Science Foundation.